Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 447, doi. 10.23736/S2724-6507.22.03723-X
- By:
- Publication type:
- Article
Works matching IS 27246507 AND DT 2023 AND VI 48 AND IP 4
Results: 14
1
2
Long-term surveillance of a Von Hippel-Lindau disease pituitary stalk hemangioblastoma.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 473, doi. 10.23736/S2724-6507.23.03885-X
- By:
- Publication type:
- Article
3
Does glycemic control improve diabetic polyneuropathy?
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 474, doi. 10.23736/S2724-6507.22.03877-5
- By:
- Publication type:
- Article
4
Association of overweight and obesity with vertebral fractures: a systematic review and meta-analysis.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 459, doi. 10.23736/S2724-6507.21.03397-2
- By:
- Publication type:
- Article
5
Exploration of the molecular mechanism of insulin resistance in adipose tissue of patients with type 2 diabetes mellitus through a bioinformatic analysis.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 440, doi. 10.23736/S2724-6507.22.03771-X
- By:
- Publication type:
- Article
6
Breastfeeding is associated with a delayed decrease in postprandial maternal glucose concentration.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 432, doi. 10.23736/S2724-6507.23.03962-3
- By:
- Publication type:
- Article
7
Microrna-365-3p inhibits bone marrow mesenchymal stem cell differentiation into islet-like cell clusters via targeting Pax6 and inhibiting the MEK/ERK pathway.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 420, doi. 10.23736/S2724-6507.21.03389-3
- By:
- Publication type:
- Article
8
The impact of growth hormone replacement therapy on adipokines, but not upon ghrelin.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 411, doi. 10.23736/S2724-6507.21.03588-0
- By:
- Publication type:
- Article
9
The prevalence of primary and secondary hyperparathyroidism and its cardiometabolic implications in primary aldosteronism.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 401, doi. 10.23736/S2724-6507.23.03866-6
- By:
- Publication type:
- Article
10
Male gender as a poor prognostic factor in medullary thyroid carcinoma: behavior or biological difference?
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 395, doi. 10.23736/S2724-6507.22.03692-2
- By:
- Publication type:
- Article
11
Early stimulated thyroglobulin after thyroidectomy for thyroid cancer predicts preradioiodine therapy thyroglobulin values.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 387, doi. 10.23736/S2724-6507.22.03813-1
- By:
- Publication type:
- Article
12
The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 379, doi. 10.23736/S2724-6507.22.03663-6
- By:
- Publication type:
- Article
13
YouTube as a patient-information source for hypothyroidism.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 371, doi. 10.23736/S2724-6507.22.03732-0
- By:
- Publication type:
- Article
14
Intermittent fasting: a new trend or a valid approach for the treatment of obesity?
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 4, p. 367, doi. 10.23736/S2724-6507.23.04100-3
- By:
- Publication type:
- Article